Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Clene (CLNN) Cost of Revenue (2021 - 2025)

Clene has reported Cost of Revenue over the past 5 years, most recently at $23000.0 for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 27.78% year-over-year to $23000.0; the TTM value through Dec 2025 reached $43000.0, down 38.57%, while the annual FY2025 figure was $43000.0, 38.57% down from the prior year.
  • Cost of Revenue for Q4 2025 was $23000.0 at Clene, up from $20000.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $555000.0 in Q2 2021 and troughed at -$523000.0 in Q4 2021.
  • A 5-year average of $20400.0 and a median of $18000.0 in 2024 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 442.86% in 2023 and later crashed 72.73% in 2024.
  • Year by year, Cost of Revenue stood at -$523000.0 in 2021, then skyrocketed by 101.34% to $7000.0 in 2022, then skyrocketed by 442.86% to $38000.0 in 2023, then plummeted by 52.63% to $18000.0 in 2024, then increased by 27.78% to $23000.0 in 2025.
  • Business Quant data shows Cost of Revenue for CLNN at $23000.0 in Q4 2025, $20000.0 in Q1 2025, and $18000.0 in Q4 2024.